Medica, one of the biggest medical technology trade fairs in the world, welcomes numerous international exhibitors and experts from the healthcare sector every year. Over 5,200 exhibitors will be present at this year’s edition, including several innovative Luxembourg companies that are advancing the frontiers of medical care.

The aim is to understand the market of IVD and medical device market.

Khalouche Cana, R&D and QA Manager at Abraca BioSystems, explains that the company can offer a flexible partnering model for the (co-) development and commercialisation of new solutions. It is part of the Luxembourg delegation this year. R&D Coordinator Schauli Frederic and Quality Manager Borges Emilia will be present at the fair..

What does your company offer in the field of health technologies?

Abraca BioSystems serves the life sciences industry developing innovative technologies based on microporous silica-polymer membranes. In these applications, the membranes are used as matrix to graft chemical species onto silica to create activated or functionalised membrane.

Abraca BioSystems offers different partnering options for the (co-) development and commercialisation of new solutions.

Our products have practical applications in research labs, pharma and biotech manufacturing and diagnostics. There is an opportunity to solve complex separation and purification challenges with ion exchange membranes and affinity membranes. The matrix can be tailored to meet highly specific needs from demanding bio-based markets. They uniquely combine membrane technology, chromatographic properties and disposable usage in a single product.

What is the objective of your participation at Medica?

The aim is to understand the market of IVD and medical device market. With a flexible partnering model, Abraca BioSystems offers different partnering options for the (co-) development and commercialisation of new solutions.

What advantages does Luxembourg offer to companies in the healthtech field?

Luxembourg offers the opportunity to connect the various players in the healthech sector, and above all, to find a common interest between these companies.

Photo credit: Abraca BioSystems

Read more

Entering the European market with ease


In recent years, Luxembourg has emerged as a dynamic hub for innovation, boasting a robust ecosystem that encompasses a multitude of incubators, accelerators, specialised agencies, investors, and innovation hubs. This thriving ecosystem has played a pivotal role in nurturing and propelling numerous successful enterprises across diverse industries onto the global stage. Top executives leading some of Luxembourg’s key structures explain what the ecosystem offers and why this might just be the smartest and most cost-effective way for a soft-landing and to gain a foothold in foreign markets.
Read more

A gateway to Europe from Japan


A delegation made up of nine innovative Japanese companies is currently visiting Luxembourg from 27 to 29 November 2023, hosted by Luxinnovation and the House of Entrepreneurship. Their objective is to find out how they could benefit from Luxembourg as a gateway to Europe and find partners who could help them expand their business to the European market.
Read more

Pioneering “gamified neuroscience” for brain disorders


Luxembourg-based company Myelin-H is developing a revolutionary software technology for the remote monitoring and management of neurological disorders. The company’s CEO, Zied Tayeb, sheds light on the company’s mission to make a difference and how a personal story sparked the conception of his startup.
Read more

Accessing the European healthtech market


Healthtech solutions are subject to rather complex regulatory requirements guaranteeing health standards and protection in the EU. Luxembourg’s national innovation agency Luxinnovation manages a range of initiatives aimed at supporting healthtech companies from strategy development to European market access.
Read more

On the road to personalised medicine


In 2008, the Luxembourg government launched its Sciences and Health Technologies Action Plan to diversify its economy, nurture health technology innovation and stimulate the shift towards personalised medicine. Fifteen years later, the country is home to internationally renowned biomedical research centres and a growing community of healthtech companies focusing, in particular, on digital health, digital medical devices and in vitro diagnostics.
Read more

Resources all news